ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,057Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 939

$1.11M Total Retail Price of All Prescriptions

Rank: 30 out of 939

746 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 746 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 746 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 12,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,138 388 S3 1 1
LISINOPRIL 743 398 2 3
LEVOTHYROXINE SODIUM 661 463 3 4
OMEPRAZOLE 603 295 4 5
METFORMIN HCL 601 312 5 8
CITALOPRAM HBR 420 182 6 15
FUROSEMIDE 411 242 7 7
TRAMADOL HCL 404 197 8 16
MELOXICAM 402 178 9 14
CEPHALEXIN 388 210 10 77
AMLODIPINE BESYLATE 361 228 11 6
CIPROFLOXACIN HCL 340 190 12 54
GABAPENTIN 315 112 13 11
CARISOPRODOL 296 0 R 14 51
ATENOLOL 294 174 15 19
POTASSIUM CHLORIDE 289 190 16 9
CARVEDILOL 281 163 17 25
NEXIUM 260 129 18 18
PRAVASTATIN SODIUM 236 109 19 13
TRAZODONE HCL 229 137 20 26
ALLOPURINOL 219 137 21 31
SIMVASTATIN 204 148 22 2
ROPINIROLE HCL 203 118 23 78
ZOLPIDEM TARTRATE 200 83 24 20
DONEPEZIL HCL 196 196 25 30
CYMBALTA 190 56 26 44
METOPROLOL TARTRATE 184 115 27 10
GLIPIZIDE 175 99 28 52
AMITRIPTYLINE HCL 175 93 R 28 38
NAMENDA 172 163 30 49
ESTRADIOL 169 53 R 31 79
HYDROCHLOROTHIAZIDE 168 127 32 12
WARFARIN SODIUM 168 126 32 17
CYCLOBENZAPRINE HCL 167 35 R 34 36
PREDNISONE 163 100 35 42
CELEBREX 152 108 36 106
SERTRALINE HCL 149 106 37 24
MEGESTROL ACETATE 144 141 R 38 136
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 75 39 23
BENAZEPRIL HCL 137 97 40 87
SULINDAC 135 63 41 226
SULFAMETHOXAZOLE-TRIMETHOPRIM 133 61 42 64
METHYLPREDNISOLONE 132 85 43 118
DICLOFENAC SODIUM 130 54 44 93
PAROXETINE HCL 129 86 45 70
ATORVASTATIN CALCIUM 128 79 46 22
PROMETHAZINE HCL 128 14 R 46 68
RANITIDINE HCL 127 37 48 35
TRIAMTERENE-HYDROCHLOROTHIAZID 127 63 48 115
PREMARIN 123 75 R 50 111
PROAIR HFA 123 52 50 41
MIRTAZAPINE 121 84 52 56
TRIAMTERENE-HCTZ 120 84 53 33
OXYCODONE HCL-ACETAMINOPHEN 120 39 S2 53 107
TAMSULOSIN HCL 117 85 55 27
CLONIDINE HCL 117 37 55 39
VENTOLIN HFA 116 49 57 80
PANTOPRAZOLE SODIUM 113 73 58 66
FENTANYL 110 46 S2 59 104
DIGOXIN 108 52 60 45
ENALAPRIL MALEATE 106 79 61 65
OXYCODONE HCL 105 30 S2 62 67
AMLODIPINE BESYLATE-BENAZEPRIL 100 59 63 58
ESCITALOPRAM OXALATE 100 73 63 61
CLOPIDOGREL 100 71 63 28
ENDOCET 98 27 S2 66 148
LOSARTAN POTASSIUM 97 57 67 29
MECLIZINE HCL 96 52 68 134
LYRICA 93 19 69 63
METOPROLOL SUCCINATE 93 72 69 21
ADVAIR DISKUS 92 58 71 60
QUETIAPINE FUMARATE 90 71 72 69
SPIRONOLACTONE 89 67 73 71
BYSTOLIC 87 71 74 132
ABILIFY 87 24 74 156
ISOSORBIDE MONONITRATE ER 86 51 76 53
PLAVIX 86 55 76 48
GLYBURIDE 85 29 R 78 89
MUPIROCIN 85 33 78 185
METHADONE HCL 75 23 S2 80 109
BUPROPION HCL SR 75 14 80 196
DOXYCYCLINE HYCLATE 75 40 80 84
FLUOXETINE HCL 75 45 80 47
RISPERIDONE 74 57 84 82
DOXEPIN HCL 73 46 85 214
AMPHETAMINE SALT COMBO 70 0 S2 86 295
DIOVAN 70 45 86 50
LOVASTATIN 70 50 86 46
KLOR-CON 10 68 48 89 158
OXYBUTYNIN CHLORIDE 68 51 89 125
SUCRALFATE 67 48 91 96
DETROL LA 66 52 92 155
IBUPROFEN 65 18 93 112
POLYETHYLENE GLYCOL 3350 64 33 94 57
KLOR-CON 8 62 23 95 250
LEXAPRO 61 41 96 201
LANSOPRAZOLE 61 14 96 177
CEFUROXIME 60 34 98 166
ACTOS 60 37 98 141
NAPROXEN 60 25 98 72
TIZANIDINE HCL 60 0 98 81
RAMIPRIL 57 38 102 91
METHOTREXATE 56 20 103 240
LANTUS 55 26 104 59
AZITHROMYCIN 54 16 105 32
INSULIN SYRINGE 54 11 105 97
ALBUTEROL SULFATE 54 47 105 171
BACLOFEN 50 13 108 157
METRONIDAZOLE 50 30 108 238
SPIRIVA 50 31 108 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.